Breakthrough Drug for Covid-19 May Be Risky for Mild Cases


By BY RONI CARYN RABIN
Health
https://ift.tt/3fUNEV9
That study about dexamethasone has arrived with a big asterisk: While it appears to help severely ill patients, it harms others.
New York Times
your-feed-science, Coronavirus (2019-nCoV), Dexamethasone (Drug), Clinical Trials, Immune System, Drugs (Pharmaceuticals), Steroids
June 24, 2020 at 11:26PM

Popular posts from this blog

Why Do We Think It's Okay to Invade Strangers' Privacy?

Why American Spies Worry When Trump Meets Putin